Request Demo
Last update 23 Jan 2025
Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Interferons, Biosimilar |
Synonyms Interferon beta-1a biosimilar (Reliance Life Sciences Pvt Ltd.), ReliBeta |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 12364
The sequence is quoted from: *****
Related
3
Clinical Trials associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)CTRI/2015/08/006093
An International, Multi-centric, Comparative, Randomized, Parallel group, double-blind, placebo-controlled, phase III clinical trial study to evaluate safety and efficacy of the drug products ReliBeta (Reliance Life Sciences Pvt. Ltd.â??, India) versus Avonex (Biogen Idec Limited, Great Britain) in the treatment of patients with remitting multiple sclerosis and open after-treatment with Interferon β1а - REAV
CTRI/2018/02/011802
A single arm, single-dose, safety and pharmacokinetic study of ReliBeta® (Interferon beta-1a 2x30 micrograms pre-filled syringe) from Reliance Life Sciences Pvt. Ltd., India in normal, healthy, adult, human subjects under fasting conditions.
CTRI/2009/091/000655
Prospective, multicentre, open label, clinical study to evaluate efficacy and safety of R-TPR-011 in patients with multiple sclerosis.
100 Clinical Results associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
Login to view more data
100 Translational Medicine associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
Login to view more data
100 Patents (Medical) associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
Login to view more data
100 Deals associated with Interferon beta-1a biosimilar(Reliance Life Sciences Pvt Ltd.)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Multiple Sclerosis | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free